Biocatalysis: As pharmaceutical manufacturers increasingly use enzymatic reactions in their processes, a robust business model still eludes biocatalysis companies

Chemical and Engineering News

Volumn 90, Issue 22, 2012, Pages 13-18

  Thayer, Ann M ^a  

^a NONE

Author keywords

Active pharmaceutical ingredients; Enzymes; Fine chemicals; Process chemistry

Indexed keywords

EID: 84861717687     PISSN: 00092347     EISSN: 1520605X     Source Type: Trade Journal    
DOI: 10.1021/cen-09022-cover1     Document Type: Article

References (0)